Proper generation and conduction of the cardiac electrical impulse is essential for the continuous coordinated contraction of the heart. Dysregulation of cardiac electrical function may lead to cardiac arrhythmias, which constitute a huge medical and social burden. Identifying the genetic factors underlying cardiac electrical activity serves the double purpose of allowing the early identification of individuals at risk for arrhythmia and discovering new potential therapeutic targets for prevention. The aim of this review is to provide an overview of the genes and genetic loci linked thus far to cardiac electrical function and arrhythmia. These genes and loci have been primarily uncovered through studies on the familial rhythm disorders and through genome-wide association studies on electrocardiographic parameters in large sets of the general population. An overview of all genes and loci with their respective effect is given.
INTRODUCTION
Proper generation and conduction of the cardiac electrical impulse, which relies on the orchestrated opening and closing of ion channels in cardiac myocytes, is essential for the continuous coordinated contraction of the heart. Disruption of proper cardiac electrical function may lead to potentially fatal arrhythmias which constitute a huge medical and social burden. Since the pioneering work of Keating et al. in mapping chromosomal loci underlying the long QT syndrome (LQTS) [1, 2] , a familial (Mendelian) rhythm disorder causing sudden cardiac death (SCD) in the young, huge progress has been made in identifying genes underlying normal and abnormal cardiac electrical function. The identification of such genes is important as it serves the double purpose of allowing the early identification of individuals at risk of SCD and the discovery of new potential therapeutic targets for prevention.
We here provide an overview of the genes and genetic loci linked thus far to cardiac electrical function and arrhythmia. These genes and loci have been primarily uncovered through studies on the rare familial rhythm disorders and more recently, through genome-wide association studies (GWAS) on electrocardiographic (ECG) parameters in large sets of the general population. An overview of all genes and loci with their respective effect is given in Table 1 .
GENETICS OF THE RARE CARDIAC RHYTHM DISORDERS
A wide spectrum of the rare familial rhythm disorders associated with SCD in the young is nowadays recognized. These disorders, which are typically associated with specific features on the ECG, include amongst others the LQTS, the short QT syndrome (SQTS), Brugada syndrome (BrS), cardiac conduction disease (CCD), early repolarization (ER) syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT) and familial atrial fibrillation (FAF). The identification of genes for these disorders has had a major impact on patient care, as reflected in the HRS/EHRA Expert Consensus Statement on the state of genetic testing for the channelopathies and cardiomyopathies published in 2011 [3] . Risk of sudden death" SCD Case^control association study of candidate SNPs [40] (continued) C1orf185, RNF11, CDKN2C, FAF1
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Long QT syndrome
The LQTS, characterized by a prolonged (heart rate corrected) QT interval (QTc) on the ECG and a high incidence of malignant ventricular arrhythmias, has thus far been linked to 14 genes (see Table 1 , for the genes and references). Genetic testing has become a routine procedure in the diagnosis of LQTS, and mutations in the three major LQTS susceptibility genes KCNQ1 (LQT1), KCNH2 (LQT2) and SCN5A (LQT3) are found in 70-75% of cases [4] . The presence of known pathogenic mutations aids in the diagnosis of patients with borderline clinical manifestations, even up to the point where sequencing has become the gold standard for the diagnosis of relatives of probands with a known mutation [5] .
Short QT syndrome
In contrast to the prolonged QTc-interval in LQTS, SQTS is characterized by an abbreviated QTc-interval. Like LQTS, the SQTS is characterized by a high risk of ventricular arrhythmias [6] . Gain of function mutations (increasing the repolarizing potassium current) in KCNH2, KCNQ1 and KCNJ2 have been identified as a cause of the disorder (see Table 1 for details).
Brugada syndrome
Patients with BrS are identified by the trademark ECG feature of ST-segment elevation in the right precordial leads. Patients presenting with BrS are predominantly male (male:female ratio 8:1) [7] . The most frequent genetic cause is loss of function mutations in SCN5A (BrS1), but mutations have also been described in 11 other genes (BrS2-12, see Table 1 for details).
ER/J-wave syndrome
An ER pattern on the ECG, consisting of a distinct J wave or J point elevation, a notch or slur of the terminal part of the QRS complex and an STsegment change is generally found in healthy young males and has traditionally been viewed as benign [8] . However, recent reports [9, 10] indicate that ER is linked to malignant ventricular fibrillation (VF) and that mutations in KCNJ8, CACNA1C, CACNAB2b, CACNA2D1 and SCN5A can be involved (Table 1 and [11] for a review of the current knowledge). CPVT is characterized by sympathetically mediated ventricular arrhythmias in the absence of structural heart disease; symptoms usually present early in life [12] . CPVT is caused by a deregulation of the calcium release from the sarcoplasmic reticulum, most commonly as a result of a mutation in the ryanodine receptor protein RYR2, although homozygous and compound heterozygous mutations in CASQ2 have also been found [13] . Recently, mutations in TRDN and CALM1 have been identified through a candidate gene approach and linkage studies, respectively in patients with CPVT [14, 15] .
Familial atrial fibrillation
FAF as defined by multiple individuals in a family with lone AF at young age has been associated with variants in KCNQ1 through linkage studies [16] , variants in other potassium channel subunits, SCN5A [17] and GATA4 [18, 19] have been implicated in the risk for FAF, through candidate gene analysis.
Sick sinus syndrome
Sick sinus syndrome is arbitrarily defined as heart rate lower than 60 beats per minute. Familial forms of primary sinus bradycardia have been recognized and have been attributed to mutations in HCN4 [20] , SCN5A [21, 22] and ANKB [23] .
Cardiac conduction disease
CCD or atrial-ventricular block is sometimes seen as co-morbidity with some of the other syndromes described above (e.g. BrS, LQTS) but does occur in isolation as well. Familial forms have been associated with mutations in TRPM4 [24] , SCN5A [25] , SCN1B [26] and NKX2.5 [27] .
In summary, the great majority of the genes implicated in the inherited arrhythmia syndromes encode cardiac ion channel subunits or regulators of ion homeostasis (e.g. Ca 2þ regulation in CPVT). It is however important to realize that with the exception of a few early studies [28, 29] , most genes have been implicated through candidate gene studies, with limited segregation analysis (if any) due to the unavailability of extended pedigrees, in combination with in vitro functional studies. For many genes, additional studies including investigation of mutation prevalence in large patient sets will be required to shed light on the actual involvement of certain genes in the disease.
GENOME-WIDE ASSOCIATION STUDIES OF CARDIAC ELECTRICAL PHENOTYPES
While the familial rhythm disorders are an important cause of sudden death in the young, the vast majority (80%) of SCDs in the community occurs in individuals above 40 years of age and is primarily caused by VF in the setting of acute myocardial ischemia or acute or prior myocardial infarction, sequelae of coronary artery disease [30] . Paradoxically, progress in uncovering the genetic factors that determine susceptibility to these common arrhythmias, affecting a much greater proportion of the population, has been limited and has only recently started to be explored. Similarly, for atrial fibrillation (AF), the most common sustained arrhythmia with an age dependent prevalence of up to 9% [31] , although a strong heritability has been demonstrated, the genes conferring risk remain largely elusive. Both VF/SCD in the general population and AF are complex phenotypes and as such they are thought to be attributable at least in part to common allelic variants, i.e. variants present in more than 1-5% of the population. Such common variants are expected to be associated with small effects and as such will individually confer only relatively small increments in risk (1.1-to 1.5-fold) and explain only a small proportion of the heritability. A role for such variants in susceptibility to SCD and AF has recently started to be explored in GWAS (see Table 1 for the identified loci).
Although genetic studies in patient sets with AF and ischemia-related VF have started to uncover the underlying genetic variation [32, 33] , complementary strategies to identify genes and mechanisms underlying cardiac electrical activity and susceptibility to arrhythmia remain essential. Case-control studies in humans are hampered by the difficulties in collecting patient sets of sufficient magnitude. For ischemiamediated VF in particular, collection of large patient sets is difficult since most SCD victims die before they are reached by medical help; this precludes not only ascertainment of the exact cardiac pathology associated with the arrhythmia (hindering the deep-phenotyping desired for statistically powered genetic association studies) but also acquisition of a DNA sample. An alternative to building direct bridges between genetic variation and arrhythmia susceptibility entails the dissection of the genetic factors that underlie phenotypes involved in arrhythmogenesis (commonly referred to as intermediate phenotypes). Many research groups have consequently turned to the identification of genetic variants that modulate the various ECG parameters, such as heart rate, and conduction (PR-interval, QRS duration) and repolarization (QTc-interval) indices. Twin studies have shown that a large proportion of the variability in the ECG parameters is heritable [34] and although the evidence is sparse, studies in the general population indicate that the duration of certain ECG parameters is related to risk of cardiac arrhythmia (e.g. QTc-interval duration for SCD [35] and PR-interval duration for AF [36] ). As ECG indices are readily quantifiable and thus amenable to genetic studies, various ECG traits (e.g. heart rate, QRS duration, QTc-and PR-interval) have been studied by GWAS for identification of common genetic variants that govern the variability of these ECG intervals in the general population (reviewed in [37] ).
GWAS studies take advantage of the availability of inexpensive single nucleotide polymorphism (SNP) arrays that interrogate a large part of the common genetic variation spread across the genome. This information is then coupled in many individuals to the duration of the trait of interest to systematically examine whether genotype is significantly associated with differences in phenotype (e.g. QTc-interval duration). It is important to notice that due to the nature of the (haplotype-tagging) approach, such studies in general do not yield the causal gene or causal variant, but rather a marker of the haplotype involved at the associating locus. Loci identified thus far by GWAS for complex arrhythmias or ECG parameters are listed in Table 1 . Where the found associations are in regions with clear candidate genes, called on the basis of functional data in the literature, the GWAS signal is listed under the respective gene in the table. For the many loci for which no such data are available, the locus is mentioned in the table, with the closest gene(s) indicated in the remarks (likely candidates among these genes are highlighted in bold).
The first GWAS on cardiac electrical function was performed in 2006 by Arking and colleagues, who identified a common variant at the NOS1AP locus in a small set of individuals representing the extremes of a population sample based on the distribution of QTc-intervals; in this study, the association of this locus with QTc-interval was subsequently validated in two independent study populations [38] . This locus has since also been validated in multiple independent studies [39] [40] [41] . Of note, common variants at the NOS1AP locus have been shown to associate with the risk of SCD [40] in the general population and were shown to modulate the QT-interval duration and risk of arrhythmias in the LQTS in two studies [42, 43] . This early study immediately demonstrated the power of GWAS to identify genetic loci that were previously not linked to cardiac electrical function providing possibilities for novel mechanistic insight. NOS1AP encodes the cardiac protein CAPON, an interaction partner of nitric oxide synthase-1 (NOS1) that enhances nitric oxide (NO) production [44] , which in turn are both known players in cardiac physiology (e.g. calcium turnover and adrenergic response) [44] [45] [46] .
Many loci identified thus far by GWAS for ECG parameters unsurprisingly harbor genes encoding ion channel subunits, most already known from the rare cardiac rhythm disorders. These results indicate that genetic variability within these genes besides conferring risk for SCD in the Mendelian rhythm disorders also underlies variability of the associated ECG traits in the general population and may thus play a role in susceptibility to the more common arrhythmias affecting a larger portion of the population, as already indicated in some studies [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] . Furthermore, candidate gene studies have also demonstrated that common genetic variants at the ion channel loci associate with the risk of SCD in the general population [40, 58] . The identification of common genetic variants in these genes modulating the ECG-intervals in the general population is consistent with the concept that genes harbor a spectrum of variants ranging from rare highly deleterious variants leading to Mendelian disease to common small-effect variants that may in aggregate impact on susceptibility to complex disease in the general population. Besides NOS1AP and the ion channels subunits, transcription factors known to be involved in cardiac development (e.g. NKX2.5, PITX2 and TBX5 [33, 36, [50] [51] [52] [59] [60] [61] [62] ) and Ca 2þ homeostasis genes (CASQ2 and RYR2 [40, 63] ) have also been identified as candidates for variability of the ECG parameters (NKX2.5 and TBX5), risk factors for SCD (CASQ2 and RYR2) and AF (PITX2) in the general population. The finding of these developmental transcription factors illustrates the challenge to link the vast information on genetic variation in developmental genes to function and the myocardial electrical properties or qualitative arrhythmias in the adult human population.
One of the GWAS loci that has been found in many independent studies for several cardiac electrical properties is the SCN5A/SCN10A locus [17, 25, 28, [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] 58, [64] [65] [66] . Independent GWAS signals at chr3p22 harboring SCN5A and SCN10A juxtaposed at 60 kb from each other) have been identified for QTc-interval, QRS duration and PR-interval. Furthermore, the locus has been implicated in the risk of SCD in the general population in a candidate gene study [58] . However, no consensus has yet been reached on the question whether all of the effects found at this locus are mediated through SCN5A alone [67] or whether some of the effects are attributable to SCN10A [53, 68] .
There is robust evidence for the link between common variation at the 4q25 locus and the risk of AF [33, [59] [60] [61] [62] . PITX2 one of the genes located in this region encodes a homeobox transcription factor involved in early left/right determination and the development of the pulmonary myocardium during embryogenesis [69, 70] . Mice heterozygously lacking Pitx2 have inducible AF [70, 71] . Furthermore, PITX2 seems to be downregulated in patients with AF [72] . PITX2 is therefore a very clear candidate gene for the chromosome 4q25 risk locus for AF.
The identification of the actual causal gene and variant at the various GWAS loci is likely to be a laborious task and will take time to decipher. Many of the associated SNPs tag haplotypes that occur in non-coding regions of the genome and lie in intergenic and intronic regions [73] . It is thus most likely that the causal SNP(s) at these loci influences the trait by affecting gene expression levels. The challenge facing the scientific community now is to link these genomic loci to changes in cardiac transcript levels (by the identification of so called expression quantitative trait loci or eQTLs) [74] , and then overlaying such eQTL data with GWAS data in order to point towards candidate genes at the GWAS loci for downstream functional validation studies. Unfortunately, due to the difficulty in obtaining healthy donor tissue from human hearts no human cardiac eQTL database is yet available. This approach has however worked in other disease types such as childhood asthma, where ORMDL3 was identified as candidate gene from a list of 19 all equally unlikely candidates [74, 75] . In the heart, overlaying cardiac eQTL data with phenotypic quantitative trait loci in a murine F2 study implicated Tnni3k in PR-interval prolongation [76] . Further integration of available genome-wide data sets such as ChIPseq data of cardiac tissue [67] and the ENCODE project data [77] will help further to identify the causal variants for further functional studies.
MISSING HERITABILITY
Even though the list in Table 1 is by no means short and the progress in identifying the genetic factors underlying the heritability of cardiac electrical function has been tremendous, as most of the GWAS loci are associated only with small effect sizes (e.g. effect on ECG parameters < 2 ms) or a small increase in risk (odds ratios <2 are typical), a large proportion of the heritability remains unexplained [78] . The phenomenon of missing heritability is not limited to the heritability of cardiac electrical traits but has been observed for almost all multifactorial traits studied by GWAS in humans [78, 79] . Missing heritability has been attributed to a number of possible causes: (i) the effects of found loci may be diluted when the causal variant is present in only a proportion of the individuals carrying the SNPs tagging the causal variant; (ii) rare variants with larger effect sizes than the loci found thus far may be too rare to have been picked up by the current GWAS strategies; (iii) part of the heritability may be hidden in genomic variation that is not directly visible on SNP arrays such as copy number variations and epigenetic changes; and (iv) part of the heritability may be caused by epistatic interaction between the different, already identified loci which creates the impression of a higher 'phantom' heritability than the individual traits would warrant [78] [79] [80] . In the light of the possible dilution, missed variants and phantom heritability, it is interesting to note that recent studies in yeast, where the entire genetic structure is known, found a 'missing missing heritability'; nearly all (80-100%) of the heritability of different growth rate phenotypic traits was explained by the identified loci [81, 82] . This phenomenon argues in favor of sequencing the entire genome of case-control sets rather than expanding the numbers of individuals included in future GWAS experiments; however, aside from the clear computational difficulties this will entail, for the VF/SCD phenotype in particular, the challenge will be in the collection of sufficiently large phenotypically well-characterized patient sets.
SUMMARY
In the rare familial rhythm disorders, many genes have been identified that underlie the observed phenotype. Most of these encode cardiac ion channel subunits that are essential for the proper generation and propagation of the cardiac action potential. GWAS recently identified multiple genetic loci underlying variability in the ECG traits or risk of cardiac arrhythmias. These GWAS loci yielded novel candidate genes for which functional studies are likely to provide new mechanistic insight into cardiac electrical function. Future studies will address whether the loci identified as modifiers of ECG parameters may be useful for risk stratification in patient sets. The challenge for the future will also entail the identification of both the causal variants at the loci identified by GWAS as well identifying the loci underlying the missing heritability.
Key Points
The rare cardiac rhythm disorders are largely caused by mutations in genes encoding cardiac ion channel subunits. GWAS have recently identified multiple genetic loci that modulate the various ECG traits or the risk of cardiac arrhythmia. Several of the newly identified GWAS loci yielded novel candidate genes. Downstream functional studies of these newly identified genes are likely to provide novel mechanistic insight into cardiac electrical function. These genetic loci await extensive testing in patients with cardiac arrhythmia in order to determine their role in modulation of arrhythmia risk. The challenge for the future lies in identifying both the loci underlying the missing heritability and the causal variants at the identified loci. 
